Clinical Trials Directory

Trials / Terminated

TerminatedNCT03168282

Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico

Status
Terminated
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Mexican Emerging Infectious Diseases Clinical Research Network · Network
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of this study is to determine the feasibility of identifying novel etiologic agents associated with SARI in patients who have required intubation and in whom, after analysis, a causative agent was not identified by standard microbiologic (culture) and multiplex real-time Polymerase Chain Reaction (PCR) platforms. Taking into account that isolation of any pathogens is generally time sensitive, the study will evaluate subjects that are culture negative at the time of consent. Not all subjects will actually prove to be culture negative. Additionally, the study will compare etiologic agents identified on broncho-alveolar lavage (BAL) to etiologic agents identified by routine upper airway testing on all subjects with SARI.

Conditions

Timeline

Start date
2017-04-06
Primary completion
2018-04-11
Completion
2018-04-11
First posted
2017-05-30
Last updated
2018-11-06

Locations

3 sites across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03168282. Inclusion in this directory is not an endorsement.